Zhitong Finance App News, Eddy Pharmaceutical (688488.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for darunavir tablets approved and issued by the State Drug Administration. Darunavir tablets are another anti-HIV treatment approved by the company. It is the first domestically modeled approved variety, and there are currently no other drugs containing darunavir active ingredients on the market for sale in China.

This drug, in combination with ritonavir (darunavir/ritonavir) and other antiretroviral drugs, is suitable for the treatment of human immunodeficiency virus type 1 (HIV-1) patients infected with human immunodeficiency virus type 1 () in adults and children aged 3 years and over (and body weight ≥40 kg) who have undergone antiretroviral treatment (ART) and have at least one darunavir resistance-related mutation or are unable to perform HIV-1 genotype testing.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.